[ad_1]
Washington – SANA
The US Food and Drug Administration (FDA) has approved the world's first drug to treat cancer from its source, which could revolutionize the world of health.
The drug "Vitrakvi" s' attack genetic mutations of tumors, regardless of their type or place of origin, where it targets the original gene that caused the onset of the tumor.
Commission Commissioner Dr. Scott Gottlieb said that approval is an important step in treating cancer based on tumor genes, adding that it would help patients get the right treatment in the best possible way. delays because it was not available a decade ago.
Gottlieb stresses that the drug, which will come in the form of tablets or syrup for children, will help cure patients with different cancers and will include common genetic mutations. Doctors will be able to prescribe it to these patients if the tumor is due to abnormal genes or if cancer cells spread in the body or if the surgery to eliminate cancer will cause complex complications and will be used if the cancer does not respond to other treatments and spreads further.
It is worth mentioning that the treatment experience in humans, where a case of recovery of a girl who has been infected with the disease after months of doctors to maintain the prescribed doses.
Source link